Top segments and regional performance

Last year, the company generated ‪3.44 B‬ USD, the most of which — ‪1.21 B‬ USD — came from its top-performing segment, Bruker Scientific Instruments Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection, compared to ‪1.09 B‬ USD the previous year. The greatest contribution came from Rest of Europe, which accounted for ‪950.20 M‬ USD last year, with ‪873.00 M‬ USD the year before.